Ace Alera Clinical Chemistry System, Ace Glucose Reagent, Ace Ion Selective Electrode (Ise) Module
by Alfa Wassermann Diagnostic Technologies, Inc.
510(k) K123018
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK123018 | Date23 Apr 2013 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- CFR
- Device Class
- Class II
- Regulation
- 21 CFR Part 862.1345
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 6 Oct 2026
The ACE ALERA CLINICAL CHEMISTRY SYSTEM, ACE GLUCOSE REAGENT, ACE ION SELECTIVE ELECTRODE (ISE) MODULE is a clinical chemistry system used for measuring analytes in serum and plasma. It includes a glucose reagent based on the hexokinase method and an ion selective electrode module for sodium, potassium, and chloride measurements.
The system is supplied for use in physician office laboratories, small hospitals, veterinary practices, and research facilities. It is a traditional 510(k) cleared device (K123018) with FDA authorization, classified as a class II medical device under regulation number 862.1345 for clinical chemistry.
Other devices from Alfa Wassermann Diagnostic Technologies, Inc.
See all devices from Alfa Wassermann Diagnostic Technologies, Inc. →
Questions
AI-generated answers, 6 Oct 2026
What is the ACE ALERA Clinical Chemistry System used for?
The ACE ALERA Clinical Chemistry System is used for measuring analytes in serum and plasma, specifically glucose using the hexokinase method and sodium, potassium, and chloride using the ion selective electrode (ISE) module.
How is the ACE ALERA system supplied and where is it intended for use?
The system is supplied for use in physician office laboratories, small hospitals, veterinary practices, and research facilities as a traditional 510(k) cleared device with FDA authorization under K123018.
What regulatory pathway and classification applies to the ACE ALERA system?
The ACE ALERA system is a class II medical device cleared via the traditional 510(k) pathway (K123018) and is regulated under 21 CFR 862.1345 for clinical chemistry systems.